About
"In the past decade, novel cancer immunotherapy strategies have contributed to the successful treatment of many end-stage cancer patients; yet we are just at the beginning of the road in curing all cancer (sub-)types. Hence, a better understanding of the fundamental interactions between the immune system and malignant cells is required to help achieve this goal."
As a cancer immunotherapy researcher, Dr Ali Roghanian is interested in studying tumour-mediated immunosuppression and the application of targeted therapies to promote an effective anti-tumour immunity. To achieve this, the group is using innovative technologies, including a combination of advanced preclinical models of human cancers (e.g., PDX, CDX, humanized) and complementary platforms (e.g., syngeneic models, cell cultures), and novel reagents (e.g., monoclonal antibodies) and other modalities (e.g., cellular therapies).
You can update this in . Select 鈥楨dit profile鈥. Under the heading and then 鈥楥urriculum and research description鈥, select 鈥楢dd profile information鈥. In the dropdown menu, select - 鈥楢bout鈥.
Write about yourself in the third person. Aim for 100 to 150 words covering the main points about who you are and what you currently do. Clear, simple language is best. You can include specialist or technical terms.
You鈥檒l be able to add details about your research, publications, career and academic history to other sections of your staff profile.
Research
Research interests
- Cancer immunotherapy
- Monoclonal antibodies
- Cellular therapies (e.g., CAR T and iNKT cells)
- Immunoinhibitory receptors (e.g., LILRBs and Fc纬RIIB)
- Advanced pre-clinical models (e.g., PDX and humanized)
Current research
Dr Roghanian鈥檚 research interests primarily focus on advancing cancer immunotherapy and the role of inhibitory receptors (e.g., Fc纬RIIB, LILRBs), expressed on immune cells and certain tumours. In particular his group is interested in exploring the ways in which targeting these inhibitory receptors with bespoke monoclonal antibodies (mAb) may activate tumour-associated macrophages and myeloid-derived suppressor cells against the tumour cells.
Other research projects within the group are developing novel chimeric antigen receptor (CAR) cellular therapies, to help treat 鈥榗ancers of unmet need鈥 and 鈥榟ard-to-treat鈥 cancers.
Collectively, these studies will help overcome therapy resistance, often seen in patients, and to enhance conventional cancer therapies by conditioning the immune system to more efficiently eradicate malignant cells. Ultimately, the group aims to translate its basic research into therapeutics that will provide more efficacious therapies, with no/reduced side-effects, for patients in the clinic.
These ongoing projects are conducted in close collaboration with the biotechnology and pharmaceutical sectors as well as prominent academic institutions.
You can update the information for this section in .
Research groups
Any research groups you belong to will automatically appear on your profile. Speak to your line manager if these are incorrect. Please do not raise a ticket in Ask HR.
Research interests
Add up to 5 research interests. The first 3 will appear in your staff profile next to your name. The full list will appear on your research page. Keep these brief and focus on the keywords people may use when searching for your work. Use a different line for each one.
In , select 鈥楨dit profile鈥. Under the heading 'Curriculum and research description', select 'Add profile information'. In the dropdown menu, select 'Research interests: use separate lines'.
Current research
Update this in . Select 鈥楨dit profile鈥 and then 鈥楥urriculum and research description - Current research鈥.
Describe your current research in 100 to 200 words. Write in the third person. Include broad key terms to help people discover your work, for example, 鈥渟ustainability鈥 or 鈥渇ashion textiles鈥.
Research projects
Research Council funded projects will automatically appear here. The active project name is taken from the finance system.
Publications
Public outputs that list you as an author will appear here, once they鈥檙e validated by the ePrints Team. If you鈥檙e missing any outputs that you鈥檝e added to Pure, they may be waiting for validation.
Supervision
Current PhD Students
Contact your Faculty Operating Service team to update PhD students you supervise and any you鈥檝e previously supervised. Making this information available will help potential PhD applicants to find you.
Teaching
- PROG-9151- MSc Cancer Biology and Immunology (2024-Date): Co-lead for Cancer Immunology and Immunotherapy module
- MEDI3048- BM Research Project (2019-2025): Deputy Module Leader, Annual Conference Chair, Assessor, Project Supervisor
- BIOL3052 & BIOL604- Biomedical Technology (2019- ): Lecturer, Assessor
- MEDI1030- Cardiopulmonary (2019- ): Tutor
- MEDI2046- Nervous System (2019- ): Tutor
- BIOL3043 & BIOL6039- Cellular and Molecular Pathology (2020- ): Lecturer, Assessor
- NATS3006- Drugs of the future- designing a magic bullet (2020- ): Lecturer, Assessor
- BIOL3058- Biosciences Business (2018- ): Lecturer, Assessor (Dragon)
- Integrated PhD Cancer Pathway (2018- ): Project supervisor
- Personal Academic Tutor for 5 UG Medical students
You can update your teaching description in . Select 鈥楨dit profile鈥. Under the heading and then 鈥楥urriculum and research description鈥 , select 鈥楢dd profile information鈥. In the dropdown menu, select 鈥 鈥楾eaching Interests鈥. Describe your teaching interests and your current responsibilities. Aim for 200 words maximum.
Courses and modules
Contact the Curriculum and Quality Assurance (CQA) team for your faculty to update this section.
External roles and responsibilities
You can update your external roles and responsibilities in . Select 鈥+ Add content鈥 and then 鈥楢ctivity鈥, your 鈥楶ersonal鈥 tab and then 鈥楢ctivities鈥. Choose which activities you want to show on your public profile.
You can hide activities from your public profile. Set the visibility as 'Backend' to only show this information within Pure, or 'Confidential' to make it visible only to you.
Biography
Dr Roghanian obtained his PhD from the ; followed by a number of years of postdoctoral research at industry and academia, including a contract research organisation (Envigo+), the and the 黑料社. Ali was subsequently awarded a highly competitive Blood Cancer UK Visiting Fellowship in 2015 to pursue his research goals at the , USA.
Ali relocated back to Southampton in 2018 to establish his independent research group at the newly-opened Centre for Cancer Immunology.
Prizes
- Koch Institute at MIT Image Award (2016)
- Blood Cancer UK Visiting Fellowship (2016)
- Faculty of Medicine Inaugural Junior Enterprise Award (2014)
- Faculty of Medicine Staff Achievement Award (2018)
- Faculty of Medicine Staff Achievement Award (2024) (2024)
- Koch Institute at MIT Image Award (2016)
- Blood Cancer UK Visiting Fellowship (2016)
- Faculty of Medicine Inaugural Junior Enterprise Award (2014)
- Faculty of Medicine Staff Achievement Award (2018)
- Faculty of Medicine Staff Achievement Award (2024) (2024)
You can update your biography section in . Select your 鈥楶ersonal鈥 tab then 鈥楨dit profile鈥. Under the heading, and 鈥楥urriculum and research description鈥, select 鈥楢dd profile information鈥. In the dropdown menu, select - 鈥楤iography鈥. Aim for no more than 400 words.
This section will only appear if you enter the information into .
Prizes
You can update this section in . Select 鈥+Add content鈥 and then 鈥楶rize鈥. using the 鈥楶rizes鈥 section.
You can choose to hide prizes from your public profile. Set the visibility as 鈥楤ackend鈥 to only show this information within Pure, or 鈥楥onfidential鈥 to make it visible only to you.